Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic

BACKGROUND: There is growing evidence that kidney disease affects hepatically cleared drugs. Accordingly, we hypothesized that chronic kidney disease (CKD) would disrupt anticoagulation of warfarin-treated patients and thereby increase the amount of management required to maintain appropriate antico...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleinow, Megan E., Garwood, Candice L., Clemente, Jennifer L., Whittaker, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437548/
https://www.ncbi.nlm.nih.gov/pubmed/21870893
http://dx.doi.org/10.18553/jmcp.2011.17.7.523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437548/
https://www.ncbi.nlm.nih.gov/pubmed/21870893
http://dx.doi.org/10.18553/jmcp.2011.17.7.523

Ejemplares similares